|
CCNG2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.196150E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.677820E-03 |
| Normal-vs-Stage2 |
9.596800E-04 |
| Normal-vs-Stage3 |
4.395600E-04 |
| Normal-vs-Stage4 |
2.417600E-03 |
| Stage1-vs-Stage2 |
1.782370E-01 |
| Stage1-vs-Stage3 |
2.324000E-01 |
| Stage1-vs-Stage4 |
4.670200E-01 |
| Stage2-vs-Stage3 |
5.609000E-01 |
| Stage2-vs-Stage4 |
5.874400E-01 |
| Stage3-vs-Stage4 |
9.309600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.361000E-04 |
| Normal-vs-AfricanAmerican |
4.525800E-02 |
| Normal-vs-Asian |
2.002300E-02 |
| Caucasian-vs-AfricanAmerican |
8.734800E-01 |
| Caucasian-vs-Asian |
6.656200E-01 |
| AfricanAmerican-vs-Asian |
8.849600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.206000E-04 |
| Normal-vs-Female |
1.797880E-04 |
| Male-vs-Female |
9.984200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.236440E-02 |
| Normal-vs-Age(41-60Yrs) |
1.754240E-04 |
| Normal-vs-Age(61-80Yrs) |
1.88542999999264E-05 |
| Normal-vs-Age(81-100Yrs) |
5.318000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.767240E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.709500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.013200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.916790E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.191600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.893200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.004400E-01 |
| Classical-VS-Follicular |
4.41620000000142E-05 |
| Classical-VS-Other |
8.162000E-01 |
| Classical-VS-Normal |
4.620200E-03 |
| Tall-VS-Follicular |
6.664200E-02 |
| Tall-VS-Other |
6.741000E-01 |
| Tall-VS-Normal |
9.677000E-03 |
| Follicular-VS-Other |
1.393250E-01 |
| Follicular-VS-Normal |
8.59170000033771E-07 |
| Other-VS-Normal |
4.327200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.55433999999843E-05 |
| Normal-vs-N1 |
3.842500E-03 |
| N0-vs-N1 |
5.892200E-01 |
|
|
